tiprankstipranks
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market

Compass Therapeutics (CMPX) Income Statement

Compare
286 Followers

Compass Therapeutics Income Statement

Last quarter (Q3 2024), Compass Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Compass Therapeutics's net income was $-10.48M. See Compass Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Mar 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.89M$ -1.90M$ -1.62M$ -2.40M$ -2.12M
Operating Expenses
$ 48.47M$ 41.66M$ 31.26M$ 27.81M$ 34.05M
Depreciation and Amortization
$ 1.89M$ 1.90M$ 1.62M$ 2.40M$ 2.12M
EBITDA
$ -48.47M$ -37.39M$ -29.61M$ -25.32M$ -31.19M
Operating Income
$ -50.36M$ -41.66M$ -81.88M$ -27.81M$ -34.05M
Other Income/Expenses
$ 7.87M$ 2.43M$ -299.00K$ -1.66M$ -601.00K
Pretax Income
$ -42.49M$ -39.23M$ -82.18M$ -29.47M$ -34.65M
Net Income
$ -42.49M$ -36.80M$ -82.55M$ -29.50M$ -34.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.33$ -0.35$ -1.31$ -0.96$ -0.67
Diluted EPS
$ -0.33$ -0.35$ -1.31$ -0.96$ -0.67
Weighted Average Shares Outstanding
127.03M 105.19M 62.87M 30.78M 52.11M
Weighted Average Shares Outstanding (Diluted)
127.03M 105.19M 62.87M 30.78M 52.11M
Currency in USD

Compass Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis